What Researchers Did
Researchers conducted a retrospective cohort study over a 5-year period at a major tertiary hospital to analyze the association between various factors, including hyperbaric oxygen therapy, and survival outcomes in 44 patients with necrotizing soft tissue infection.
What They Found
Out of 44 patients, 6 (14%) died, and hyperbaric oxygen (HBO2) therapy was strongly associated with increased survival (P = .02), showing an odds ratio of 8.9. HBO2 therapy also significantly reduced the incidence of amputation for extremity NSTI (P = .05) and improved long-term survival (P = .002).
What This Means for Canadian Patients
Canadian patients diagnosed with necrotizing soft tissue infection may benefit from adjunctive hyperbaric oxygen therapy, which was shown to significantly improve survival and reduce the need for amputations. This suggests that access to and timely administration of HBO2 could be a crucial component of comprehensive care for this severe condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a major tertiary hospital outside of Canada.
Study Limitations
As a retrospective cohort study conducted at a single tertiary hospital with a relatively small sample size of 44 patients, the findings may not be broadly generalizable.